secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoodRx Holdings, Inc. (GDRX)
CIK:        0001809519
Form:       8-K
Filed at:   2024-07-11T23:59:59+00:00
Accession:  0001809519-24-000147
Event type: debt
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoodRx enters Sixth Amendment to Credit Agreement, refinances $500M term loan facility
--------------------------------------------------------------------------------

- New $500M 2024 Term Loan Facility matures July 2029 with SOFR + 3.75% margin, used to repay Existing Term Loans ($167.2M cash added).
- Maturity of $88M of $100M revolving credit facility extended to April 2029; remaining $12M terminates July 2025.
- Quarterly principal payments of 0.25% of original principal beginning Q2 2024, prepayment premium 1.00% if before Jan 2025.
- Financial covenant requires First Lien Net Leverage Ratio not exceeding 8.2x if revolving borrowings exceed threshold.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/0001809519-24-000147-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1809519/000180951924000147/gdrx-20240710.htm
  HTML page:      https://secwatch.observer/filing/0001809519-24-000147

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer